Background Extensive use of praziquantel for treatment and control of schistosomiasis
requires a comprehensive understanding of efficacy and safety of various doses for different …

Background Praziquantel at 40 mg/kg in a single dose is the WHO recommended treatment
for all forms of schistosomiasis, but 60 mg/kg is also deployed nationally …

Background. Schistosomiasis is one of the neglected tropical diseases causing a serious
human health problem in Ethiopia. Praziquantel is the only drug that has been used for the …

Background Controversy persists about the optimal approach to drug-based control of
schistosomiasis in high-risk communities. In a systematic review of published studies, we …

Praziquantel therapy has become an important component of any programme directed
towards schistosomiasis control. This disease being prevalent in many disadvantaged …

Background Schistosomiasis is a serious public health burden in sub-Saharan Africa.
Praziquantel is the only drug recommended by the World Health Organization to treat both …

Praziquantel is efficacious against the adult stages of all human schistosome parasites, and
has become the drug of choice for morbidity control of schistosomiasis. There is concern that …

Objective To determine whether praziquantel (PZQ) has retained its efficacy against
Schistosoma haematobium on Pemba Island after 20 years of mass administrationalbeit …

Background Treatment and morbidity control of schistosomiasis relies on a single drug,
praziquantel. Hence, there is a pressing need to develop additional therapeutics against …

Objective To evaluate the efficacy and side effects of praziquantel (PZQ) in the treatment of
schistosomiasis in Ethiopia. Methods In a cross-sectional study, stool specimens were …